The relationships between circulating biomarkers of iron deficiency and outcomes in patients with heart failure and reduced ejection fraction: insights from DAPA-HF

被引：0
|
作者：
Docherty, Kieran
Brennan, Alice
Sukumar, Shivasankar
Welsh, Paul
Ponikowski, Piotr
Petrie, Mark
Cleland, John
Solomon, Scott
Jhund, Pardeep
McMurray, John
机构：
来源：
CIRCULATION | 2024年 / 150卷
关键词：
D O I：
10.1161/circ.150.suppl_1.4141380
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
4141380
引用
收藏
页数：2
相关论文
共 50 条
  • [21] Acute changes in estimated glomerular filtration rate following initiation of dapagliflozin in patients with heart failure and reduced ejection fraction: insights from DAPA-HF
    Docherty, K. F.
    Vaduganathan, M.
    Inzucchi, S. E.
    Kober, L.
    Kosiborod, M. N.
    Martinez, F. A.
    Bengtsson, O.
    Ponikowski, P.
    Sabatine, M. S.
    Sjostrand, M.
    Solomon, S. D.
    Langkilde, A. M.
    Jhund, P. S.
    Mcmurray, J. J. V. John J. V.
    EUROPEAN JOURNAL OF HEART FAILURE, 2021, 23 : 57 - 57
  • [22] Effects of Dapagliflozin on Physical and Social Activity Limitations in Patients With Heart Failure and Reduced Ejection Fraction: An Analysis of DAPA-HF
    Docherty, Kieran
    Kosiborod, Mikhail N.
    Inzucchi, Silvio E.
    Kober, Lars
    Langkilde, Anna Maria
    Martinez, Felipe A.
    Bengtsson, Olof
    Ponikowski, Piotr
    Sabatine, Marc S.
    Sjastrand, Mikaela
    Solomon, Scott
    Jhund, Pardeep S.
    McMurray, John J.
    CIRCULATION, 2020, 142
  • [23] The DAPA-HF trial marks the beginning of a new era in the treatment of heart failure with reduced ejection fraction
    Verma, Subodh
    CARDIOVASCULAR RESEARCH, 2020, 116 (01) : E8 - E10
  • [24] Dapagliflozin and Diuretic Use in Patients With Heart Failure and Reduced Ejection Fraction in DAPA-HF (vol 142, 1040, 2020)
    Jackson
    CIRCULATION, 2020, 142 (20)
  • [25] Sex Differences in Characteristics, Outcomes, and Treatment Response With Dapagliflozin Across the Range of Ejection Fraction in Patients With Heart Failure: Insights From DAPA-HF and DELIVER
    Wang, Xiaowen
    Vaduganathan, Muthiah
    Claggett, Brian L.
    Hegde, Sheila M.
    Pabon, Maria
    Kulac, Ian J.
    Vardeny, Orly
    O'Meara, Eileen
    Zieroth, Shelley
    Katova, Tzvetana
    McGrath, Martina M.
    Pouleur, Anne-Catherine
    Jhund, Pardeep S.
    Desai, Akshay S.
    Inzucchi, Silvio E.
    Kosiborod, Mikhail N.
    de Boer, Rudolf A.
    Kober, Lars
    Sabatine, Marc S.
    Martinez, Felipe A.
    Ponikowski, Piotr
    Shah, Sanjiv J.
    Hernandez, Adrian F.
    Langkilde, Anna Maria
    McMurray, John J., V
    Solomon, Scott D.
    Lam, Carolyn S. P.
    CIRCULATION, 2023, 147 (08) : 624 - 634
  • [26] Effects of Dapagliflozin on Symptoms, Function, and Quality of Life in Patients With Heart Failure and Reduced Ejection Fraction Results From the DAPA-HF Trial
    Kosiborod, Mikhail N.
    Jhund, Pardeep S.
    Docherty, Kieran F.
    Diez, Mirta
    Petrie, Mark C.
    Verma, Subodh
    Nicolau, Jose C.
    Merkely, Bela
    Kitakaze, Masafumi
    DeMets, David L.
    Inzucchi, Silvio E.
    Kober, Lars
    Martinez, Felipe A.
    Ponikowski, Piotr
    Sabatine, Marc S.
    Solomon, Scott D.
    Bengtsson, Olof
    Lindholm, Daniel
    Niklasson, Anna
    Sjoestrand, Mikaela
    Langkilde, Anna Maria
    McMurray, John J. V.
    CIRCULATION, 2020, 141 (02) : 90 - 99
  • [27] Initial Decline (Dip) in Estimatec Glomerular Filtration Rate After Initiation of Dapagliflozin in Patients With Heart Failure and Reduced Ejection Fraction: Insights From DAPA-HF
    Adamson, Carly
    Docherty, Kieran F.
    Heerspink, Hiddo J. L.
    de Boer, Rudolf A.
    Damman, Kevin
    Inzucchi, Silvio E.
    Kober, Lars
    Kosiborod, Mikhail N.
    Martinez, Felipe A.
    Petrie, Mark C.
    Ponikowski, Piotr
    Sabatine, Marc S.
    Schou, Morten
    Solomon, Scott D.
    Verma, Subodh
    Bengtsson, Olof
    Langkilde, Anna Maria
    Sjostrand, Mikaela
    Vaduganathan, Muthiah
    Jhund, Pardeep S.
    McMurray, John J., V
    CIRCULATION, 2022, 146 (06) : 438 - 449
  • [28] Effects of dapagliflozin in heart failure with reduced ejection fraction and chronic obstructive pulmonary disease: an analysis of DAPA-HF
    Dewan, Pooja
    Docherty, Kieran F.
    Bengtsson, Olof
    de Boer, Rudolf A.
    Desai, Akshay S.
    Drozdz, Jaroslaw
    Hawkins, Nathaniel M.
    Inzucchi, Silvio E.
    Kitakaze, Masafumi
    Kober, Lars
    Kosiborod, Mikail N.
    Langkilde, Anna Maria
    Lindholm, Daniel
    Martinez, Felipe A.
    Merkely, Bela
    Petrie, Mark C.
    Ponikowski, Piotr
    Sabatine, Marc S.
    Schou, Morten
    Sjostrand, Mikaela
    Solomon, Scott D.
    Verma, Subodh
    Jhund, Pardeep S.
    McMurray, John J. V.
    EUROPEAN JOURNAL OF HEART FAILURE, 2021, 23 (04) : 632 - 643
  • [29] Defining Severe Heart Failure across the Ejection Fraction Spectrum in DAPA-HF and DELIVER
    Inciardi, Riccardo
    Lu, Henri
    Claggett, Brian
    Desai, Akshay
    Jhund, Pardeep
    Lam, Carolyn
    Kosiborod, Mikhail
    Inzucchi, Silvio
    Martinez, Felipe
    De Boer, Rudolf
    Hernandez, Adrian
    Shah, Sanjiv
    Kober, Lars
    Ponikowski, Piotr
    Sabatine, Marc
    Petersson, Magnus
    Langkilde, Anna Maria
    McMurray, John
    Vaduganathan, Muthiah
    Solomon, Scott
    CIRCULATION, 2024, 150
  • [30] Estimated Population Prevalence of Heart Failure with Reduced Ejection Fraction in Spain, According to DAPA-HF Study Criteria
    Camps-Vilaro, Anna
    Delgado-Jimenez, Juan F.
    Farre, Nuria
    Tizon-Marcos, Helena
    Alvarez-Garcia, Jesus
    Cinca, Juan
    Degano, Irene R.
    Marrugat, Jaume
    JOURNAL OF CLINICAL MEDICINE, 2020, 9 (07) : 1 - 15
12345